Phase 2
18 Years
N/A
18 Years
N/A
Not Enrolling
Both
Multiple Myeloma
Both
Multiple Myeloma
Trial Information
Inclusion Criteria:
- Multiple Myeloma patients in CR
Exclusion Criteria:
- not being able to give consent
Type of Study:
Observational
Study Design:
Allocation: Random Sample, Time Perspective: Longitudinal, Time Perspective: Prospective
Principal Investigator
Ray Powles, FRCP, FRCpath
Investigator Role:
Principal Investigator
Investigator Affiliation:
Royal Marsden NHS Foundation Trust
Authority:
United Kingdom: Research Ethics Committee
Study ID:
2123
NCT ID:
NCT00301275
Start Date:
June 2002
Completion Date:
December 2005
Related Keywords:
- Multiple Myeloma
- Multiple Myeloma
- Neoplasms, Plasma Cell
Name | Location |
|---|
